ArticleAnnals of the rheumatic diseases2022

Deletion of activin A in mesenchymal but not myeloid cells ameliorates disease severity in experimental arthritis.

Vanessa Waltereit-Kracke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.